Melatonin treatment attenuates symptoms of acute nicotine withdrawal in humans

Pharmacology Biochemistry and Behavior

Volumn 67, Issue 1, 2000, Pages 131-135

  Zhdanova, Irina V ^a   Piotrovskaya, Veronika R ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Humans; Melatonin; Mood; Nicotine withdrawal; Performance

Indexed keywords

MELATONIN; MICROCRYSTALLINE CELLULOSE; NICOTINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MOOD; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESPONSE TIME; SALIVA ANALYSIS; SMOKING CESSATION; SOMNOLENCE; TASK PERFORMANCE; WITHDRAWAL SYNDROME;

ADULT; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; NICOTINE; PSYCHOMOTOR PERFORMANCE; SALIVA; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0033661850     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00302-6     Document Type: Article

References (31)

1. The comparative effect of melatonin and diazepam on shifts in the anxiety-phobia status of rats evoked by damage to the amygdala
2. The effect of melatonin on rat behavior in a conflict situation
3. Caffeine antagonizes EEG effects of tobacco withdrawal
4. Reports of smoking withdrawal symptoms over a 21 day period of abstinence
5. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature and performance
6. Nicotine phase shifts the 6-sulphatoxymelatonin rhythm and induces c-Fos in the SCN of rats
7. Melatonin as an anxiolytic in rats: Time dependence and interaction with the central GABAergic system
8. Combined effects of diazepam and melatonin in two tests for anxiolytic activity in the mouse
9. The effects of deprivation of cigarette smoking on psychomotor performance
10. Recent advances in the pharmacotherapy of smoking
11. Symptoms of tobacco withdrawal. A replication and extension
12. Signs and symptoms of tobacco withdrawal
13. Consistency of the tobacco withdrawal syndrome
14. Correlation between salivary and serum melatonin: Dependence on serum melatonin levels
15. Effects of abstinence from tobacco smoking on physiological and psychological arousal levels in habitual smokers
16. Anxiolytic-like action of melatonin on acquisition but not performance of DRL
17. The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: Two non-invasive techniques for monitoring human circadian rhythmicity
18. Anxiolytic activity of melatonin in mice: Involvement of benzodiazepine receptors
19. Effects of abstinence from smoking on sleep and daytime sleepiness
20. Sleep-promoting effects of melatonin: At what dose, in whom, under what conditions, and by what mechanisms?
21. The tobacco withdrawal syndrome: Performance decrements assessed on a computerized test battery
22. Temporal stability and within-subject consistency of nicotine withdrawal symptoms
23. Melatonin increases photoreceptor susceptibility to light-induced damage
24. Circadian phase-dependent hypnotic effect of exogenous melatonin
25. Acetylcholine triggers L-glutamate exocytosis via nicotinic receptors and inhibits melatonin synthesis in rat pinealocytes
26. Role of melatonin in sleep and sleep disorders
27. Sleep-promoting effects of physiologic doses of melatonin in age-related insomnia
28. Melatonin: A sleep promoting hormone
29. Endogenous melatonin levels and the fate of exogenous melatonin: Age effects
30. Sleep inducing effects of low melatonin doses ingested in the evening
31. Effects of low doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans